The hemoglobin a1c testing devices market size has grown rapidly in recent years. It will grow from $2.08 billion in 2025 to $2.32 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rising prevalence of diabetes, expansion of routine blood glucose monitoring practices, improved availability of laboratory diagnostics, growing awareness of glycemic control, adoption of standardized diabetes testing protocols.
The hemoglobin a1c testing devices market size is expected to see rapid growth in the next few years. It will grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing demand for home-based diabetes monitoring, rising integration of ai-driven analytics, expansion of remote patient monitoring, growing focus on personalized diabetes care, increasing adoption of smart diagnostic devices. Major trends in the forecast period include increasing adoption of point-of-care hba1c testing, rising use of portable and handheld devices, growing integration with digital diabetes management platforms, expansion of rapid and high-accuracy assays, enhanced focus on patient-centric monitoring.
The increasing prevalence of diabetes is anticipated to accelerate the growth of the hemoglobin A1c testing devices market. Diabetes is a long-term metabolic condition characterized by elevated blood glucose levels. Hemoglobin A1c testing provides insights into an individual’s average blood glucose levels over time and is widely used for the diagnosis of type 2 diabetes, identification of pre-diabetes, and ongoing diabetes management. This testing supports effective disease monitoring and informed treatment decisions, helping to reduce the risk of complications. For example, in June 2024, data from the National Health Service, a United Kingdom-based government department, indicated that in 2023 more than half a million additional individuals in England (549,000) were identified as being at risk of developing type 2 diabetes. This increased the total number of people registered with general practitioners as having non-diabetic hyperglycemia, or pre-diabetes, to 3,615,330, compared with 3,065,825 in 2022, representing an increase of nearly 20%. As a result, the growing number of diabetes cases is expected to drive demand for hemoglobin A1c testing devices.
Leading companies in the hemoglobin A1c testing devices market are prioritizing the development of innovative offerings, including at-home or micro-sample HbA1c collection kits, to address rising demand driven by increasing diabetes prevalence, the expansion of decentralized care and telehealth models, and patient preferences for convenient and cost-effective monitoring solutions. An at-home HbA1c collection kit is a user-friendly solution that allows individuals to collect a small finger-prick blood sample, typically just a few drops, stabilize the sample for transport, and send it to a certified laboratory for accurate analysis. For instance, in February 2023, Hurdle, a United States-based diagnostics-as-a-service company, introduced a Hemoglobin A1c (HbA1c) Test through its Chronomics direct-to-consumer platform. The offering includes a home sample collection kit with finger-prick lancets and a sample card or tube, secure online registration via a personal dashboard, and courier return to partner Clinical Laboratory Improvement Amendments (CLIA)-certified laboratories. The service delivers laboratory-grade analysis with an average turnaround time of approximately three days after receipt, along with integrated result interpretation and optional one-to-one access to healthcare professionals, combining the convenience of home sampling with the accuracy and consistency of centralized laboratory testing.
In October 2023, Abbott Laboratories, a U.S.-based medical device company, entered into a partnership with WW International. This collaboration integrates Abbott's FreeStyle Libre continuous glucose monitoring technology with WeightWatchers' diabetes-focused weight management program, offering real-time glucose insights and personalized nutritional guidance to help individuals with diabetes make informed dietary choices and improve both weight management and glycemic control. WW International, Inc. is a U.S.-based company that provides services for weight loss and maintenance, fitness, and mindset, including the comprehensive Weight Watchers diet program.
Major companies operating in the hemoglobin a1c testing devices market are Arkray Inc, Abbott Laboratories, Polymer Technology Systems Inc, Bio-Rad Laboratories Inc, Menarini Group, F Hoffmann-La Roche AG, Siemens Healthineers AG, Tosoh Corporation, Trinity Biotech plc, Transasia Bio-Medicals Limited, Beckman Coulter Inc, Diazyme Laboratories Inc, EKF Diagnostics Holdings plc, HemoCue AB, OSANG Healthcare Co Ltd, Danaher, Thermo Fisher Scientific Inc., PTS Diagnostics India Private Limited, Nova Biomedical, Randox Laboratories Ltd., ACON Laboratories Inc., DiaSys Diagnostic Systems GmbH, Erba Mannheim, Green Cross Medical Science Corp., Infopia Co. Ltd., TaiDoc Technology Corporation, Werfen, Zhejiang Orient Gene Biotech Co. Ltd.
North America was the largest region in the hemoglobin A1C testing devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the hemoglobin A1C testing devices market during the forecast period. The regions covered in the hemoglobin a1c testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hemoglobin a1c testing devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the hemoglobin a1c testing devices market by increasing costs of imported sensors, reagents, electronic components, and precision analyzers. Hospitals and laboratories in North America and Europe are most affected due to reliance on imported diagnostic equipment, while Asia-Pacific faces higher production costs for export devices. These tariffs are increasing testing device prices and slowing procurement cycles. However, they are also promoting domestic manufacturing, local reagent production, and development of cost-effective point-of-care testing solutions.
The hemoglobin a1c testing devices market research report is one of a series of new reports that provides hemoglobin a1c testing devices market statistics, including hemoglobin a1c testing devices industry global market size, regional shares, competitors with a hemoglobin a1c testing devices market share, detailed hemoglobin a1c testing devices market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin a1c testing devices industry. This hemoglobin a1c testing devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hemoglobin A1c testing device serves as the analytical tool utilized in quantifying HbA1C. In this process, glucose binds to hemoglobin, forming glycated hemoglobin within an individual's blood sample. Its purpose is to monitor blood sugar levels consistently, contributing to efficient and effective diabetic management.
Two primary types of hemoglobin A1c testing devices exist, benchtop devices and handheld devices. Benchtop devices are designed for convenient usage on a laboratory workbench. Employed in laboratories to assess blood sugar levels in patients, benchtop hemoglobin A1c testing devices make use of various technologies such as ion exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay, and others. These technologies find application in hospitals, pharmaceuticals, medical devices, and laboratory testing.
The hemoglobin A1c testing device market consists of sales of automated, semi-automated, and bio-sensor-based hemoglobin A1c testing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The hemoglobin a1c testing devices market size is expected to see rapid growth in the next few years. It will grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing demand for home-based diabetes monitoring, rising integration of ai-driven analytics, expansion of remote patient monitoring, growing focus on personalized diabetes care, increasing adoption of smart diagnostic devices. Major trends in the forecast period include increasing adoption of point-of-care hba1c testing, rising use of portable and handheld devices, growing integration with digital diabetes management platforms, expansion of rapid and high-accuracy assays, enhanced focus on patient-centric monitoring.
The increasing prevalence of diabetes is anticipated to accelerate the growth of the hemoglobin A1c testing devices market. Diabetes is a long-term metabolic condition characterized by elevated blood glucose levels. Hemoglobin A1c testing provides insights into an individual’s average blood glucose levels over time and is widely used for the diagnosis of type 2 diabetes, identification of pre-diabetes, and ongoing diabetes management. This testing supports effective disease monitoring and informed treatment decisions, helping to reduce the risk of complications. For example, in June 2024, data from the National Health Service, a United Kingdom-based government department, indicated that in 2023 more than half a million additional individuals in England (549,000) were identified as being at risk of developing type 2 diabetes. This increased the total number of people registered with general practitioners as having non-diabetic hyperglycemia, or pre-diabetes, to 3,615,330, compared with 3,065,825 in 2022, representing an increase of nearly 20%. As a result, the growing number of diabetes cases is expected to drive demand for hemoglobin A1c testing devices.
Leading companies in the hemoglobin A1c testing devices market are prioritizing the development of innovative offerings, including at-home or micro-sample HbA1c collection kits, to address rising demand driven by increasing diabetes prevalence, the expansion of decentralized care and telehealth models, and patient preferences for convenient and cost-effective monitoring solutions. An at-home HbA1c collection kit is a user-friendly solution that allows individuals to collect a small finger-prick blood sample, typically just a few drops, stabilize the sample for transport, and send it to a certified laboratory for accurate analysis. For instance, in February 2023, Hurdle, a United States-based diagnostics-as-a-service company, introduced a Hemoglobin A1c (HbA1c) Test through its Chronomics direct-to-consumer platform. The offering includes a home sample collection kit with finger-prick lancets and a sample card or tube, secure online registration via a personal dashboard, and courier return to partner Clinical Laboratory Improvement Amendments (CLIA)-certified laboratories. The service delivers laboratory-grade analysis with an average turnaround time of approximately three days after receipt, along with integrated result interpretation and optional one-to-one access to healthcare professionals, combining the convenience of home sampling with the accuracy and consistency of centralized laboratory testing.
In October 2023, Abbott Laboratories, a U.S.-based medical device company, entered into a partnership with WW International. This collaboration integrates Abbott's FreeStyle Libre continuous glucose monitoring technology with WeightWatchers' diabetes-focused weight management program, offering real-time glucose insights and personalized nutritional guidance to help individuals with diabetes make informed dietary choices and improve both weight management and glycemic control. WW International, Inc. is a U.S.-based company that provides services for weight loss and maintenance, fitness, and mindset, including the comprehensive Weight Watchers diet program.
Major companies operating in the hemoglobin a1c testing devices market are Arkray Inc, Abbott Laboratories, Polymer Technology Systems Inc, Bio-Rad Laboratories Inc, Menarini Group, F Hoffmann-La Roche AG, Siemens Healthineers AG, Tosoh Corporation, Trinity Biotech plc, Transasia Bio-Medicals Limited, Beckman Coulter Inc, Diazyme Laboratories Inc, EKF Diagnostics Holdings plc, HemoCue AB, OSANG Healthcare Co Ltd, Danaher, Thermo Fisher Scientific Inc., PTS Diagnostics India Private Limited, Nova Biomedical, Randox Laboratories Ltd., ACON Laboratories Inc., DiaSys Diagnostic Systems GmbH, Erba Mannheim, Green Cross Medical Science Corp., Infopia Co. Ltd., TaiDoc Technology Corporation, Werfen, Zhejiang Orient Gene Biotech Co. Ltd.
North America was the largest region in the hemoglobin A1C testing devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the hemoglobin A1C testing devices market during the forecast period. The regions covered in the hemoglobin a1c testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hemoglobin a1c testing devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the hemoglobin a1c testing devices market by increasing costs of imported sensors, reagents, electronic components, and precision analyzers. Hospitals and laboratories in North America and Europe are most affected due to reliance on imported diagnostic equipment, while Asia-Pacific faces higher production costs for export devices. These tariffs are increasing testing device prices and slowing procurement cycles. However, they are also promoting domestic manufacturing, local reagent production, and development of cost-effective point-of-care testing solutions.
The hemoglobin a1c testing devices market research report is one of a series of new reports that provides hemoglobin a1c testing devices market statistics, including hemoglobin a1c testing devices industry global market size, regional shares, competitors with a hemoglobin a1c testing devices market share, detailed hemoglobin a1c testing devices market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin a1c testing devices industry. This hemoglobin a1c testing devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hemoglobin A1c testing device serves as the analytical tool utilized in quantifying HbA1C. In this process, glucose binds to hemoglobin, forming glycated hemoglobin within an individual's blood sample. Its purpose is to monitor blood sugar levels consistently, contributing to efficient and effective diabetic management.
Two primary types of hemoglobin A1c testing devices exist, benchtop devices and handheld devices. Benchtop devices are designed for convenient usage on a laboratory workbench. Employed in laboratories to assess blood sugar levels in patients, benchtop hemoglobin A1c testing devices make use of various technologies such as ion exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay, and others. These technologies find application in hospitals, pharmaceuticals, medical devices, and laboratory testing.
The hemoglobin A1c testing device market consists of sales of automated, semi-automated, and bio-sensor-based hemoglobin A1c testing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Hemoglobin A1c Testing Devices Market Characteristics
3. Hemoglobin A1c Testing Devices Market Supply Chain Analysis
4. Global Hemoglobin A1c Testing Devices Market Trends and Strategies
5. Hemoglobin A1c Testing Devices Market Analysis of End Use Industries
7. Global Hemoglobin A1c Testing Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Hemoglobin A1c Testing Devices Total Addressable Market (TAM) Analysis for the Market
9. Hemoglobin A1c Testing Devices Market Segmentation
10. Hemoglobin A1c Testing Devices Market Regional and Country Analysis
11. Asia-Pacific Hemoglobin A1c Testing Devices Market
12. China Hemoglobin A1c Testing Devices Market
13. India Hemoglobin A1c Testing Devices Market
14. Japan Hemoglobin A1c Testing Devices Market
15. Australia Hemoglobin A1c Testing Devices Market
16. Indonesia Hemoglobin A1c Testing Devices Market
17. South Korea Hemoglobin A1c Testing Devices Market
18. Taiwan Hemoglobin A1c Testing Devices Market
19. South East Asia Hemoglobin A1c Testing Devices Market
20. Western Europe Hemoglobin A1c Testing Devices Market
21. UK Hemoglobin A1c Testing Devices Market
22. Germany Hemoglobin A1c Testing Devices Market
23. France Hemoglobin A1c Testing Devices Market
24. Italy Hemoglobin A1c Testing Devices Market
25. Spain Hemoglobin A1c Testing Devices Market
26. Eastern Europe Hemoglobin A1c Testing Devices Market
27. Russia Hemoglobin A1c Testing Devices Market
28. North America Hemoglobin A1c Testing Devices Market
29. USA Hemoglobin A1c Testing Devices Market
30. Canada Hemoglobin A1c Testing Devices Market
31. South America Hemoglobin A1c Testing Devices Market
32. Brazil Hemoglobin A1c Testing Devices Market
33. Middle East Hemoglobin A1c Testing Devices Market
34. Africa Hemoglobin A1c Testing Devices Market
36. Hemoglobin A1c Testing Devices Market Competitive Landscape and Company Profiles
37. Hemoglobin A1c Testing Devices Market Other Major and Innovative Companies
40. Hemoglobin A1c Testing Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Hemoglobin A1c Testing Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses hemoglobin a1c testing devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hemoglobin a1c testing devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemoglobin a1c testing devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Bench Top Device; Handheld Device2) By Technology: Ion-Exchange HPLC; Immunoassay; Boronate Affinity Chromatography; Direct Enzymatic Assay; Other Technologies
3) By End Use: Hospitals; Pharmaceuticals; Medical Devices; Laboratory Testing
Subsegments:
1) By Bench Top Device: Automated Hemoglobin A1C Analyzers; Laboratory-Grade Analyzers; Multi-Parameter Testing Devices2) By Handheld Device: Portable Hemoglobin A1C Testers; Point-Of-Care Testing Devices; Smartphone-Integrated Testing Devices
Companies Mentioned: Arkray Inc; Abbott Laboratories; Polymer Technology Systems Inc; Bio-Rad Laboratories Inc; Menarini Group; F Hoffmann-La Roche AG; Siemens Healthineers AG; Tosoh Corporation; Trinity Biotech plc; Transasia Bio-Medicals Limited; Beckman Coulter Inc; Diazyme Laboratories Inc; EKF Diagnostics Holdings plc; HemoCue AB; OSANG Healthcare Co Ltd; Danaher; Thermo Fisher Scientific Inc.; PTS Diagnostics India Private Limited; Nova Biomedical; Randox Laboratories Ltd.; ACON Laboratories Inc.; DiaSys Diagnostic Systems GmbH; Erba Mannheim; Green Cross Medical Science Corp.; Infopia Co. Ltd.; TaiDoc Technology Corporation; Werfen; Zhejiang Orient Gene Biotech Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Hemoglobin A1c Testing Devices market report include:- Arkray Inc
- Abbott Laboratories
- Polymer Technology Systems Inc
- Bio-Rad Laboratories Inc
- Menarini Group
- F Hoffmann-La Roche AG
- Siemens Healthineers AG
- Tosoh Corporation
- Trinity Biotech plc
- Transasia Bio-Medicals Limited
- Beckman Coulter Inc
- Diazyme Laboratories Inc
- EKF Diagnostics Holdings plc
- HemoCue AB
- OSANG Healthcare Co Ltd
- Danaher
- Thermo Fisher Scientific Inc.
- PTS Diagnostics India Private Limited
- Nova Biomedical
- Randox Laboratories Ltd.
- ACON Laboratories Inc.
- DiaSys Diagnostic Systems GmbH
- Erba Mannheim
- Green Cross Medical Science Corp.
- Infopia Co. Ltd.
- TaiDoc Technology Corporation
- Werfen
- Zhejiang Orient Gene Biotech Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.32 Billion |
| Forecasted Market Value ( USD | $ 3.53 Billion |
| Compound Annual Growth Rate | 11.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
